ABSTRACT. We examined the ontogeny of relaxation function may vary depending on the site of binding within responses to three categories of calcium channel antagothe calcium channel. (Pediatr Res 29: 278-281, 1991) nists, represented by verapamil, diltiazem, and nifedipine, for both potential-operated (KCI-mediated) and receptorAbbreviations operated channels [norepinephrine (NE)-mediated] in rat thoracic aorta. Aortic rings from 2-to 3-d, 1-wk, and 12-wk-old Sprague Dawley rats were mounted in an organ bath, bathed in Krebs' solution, and connected to a forcedisplacement transducer to measure isometric tension. Endothelium intact vessels at optimal passive force were exposed to a single EDso of isotonic KC1 or NE, equilibrium contraction was measured, then vessels were washed and exposed for 30 min to 1 pM verapamil, 1 pM diltiazem, or 0.1 pM nifedipine, followed by another dose of KC1 or NE.
Selective calcium channel antagonists bind to specific sites in the calcium channel. Radioligand binding studies (1-3) indicate three discrete, allosterically linked binding sites for the chemical categories phenylalkylamine, benzothiazepine, and 1,Cdihydropyridine. Selective calcium channel antagonists are represented by the three prototype calcium channel antagonists verapamil, diltiazem, and nifedipine, respectively. Receptor characteristics such as I(d and B,,, have been shown to be affected by a myriad of factors, including ontogeny (4-7). However, some ontogenic studies have clearly indicated that receptor binding by calcium channel antagonists may be temporally unrelated to calcium channel function. For instance, Renaud et al. (5) demonstrated that nitrendipine (i.e. dihydropyridine) receptors exist in 3-d-old embryonic chick hearts but calcium channels, if present, are not physiologically functional.
We have previously (8) demonstrated the ontogeny of the concentration-dependent response in thoracic aortic rings among 2-d-, 1-wk-, and 1 Zwk-old rats for both potential-mediated (KClinduced) and receptor-mediated (NE-induced) contraction. Thus, calcium channel function is present from 2 d of age with perhaps increasing physiologic function during development. However, many aspects of calcium channel function during ontogeny are unknown. We therefore designed the present study to examine one aspect of calcium channel function, viz. the ontogeny of responses to three categories of calcium channel antagonists for KCI-and NE-mediated contraction in rat aorta. The objectives were 3-fold: to determine if there were 1) agerelated differences in response to selective calcium channel antagonists; 2) differential effects among the three categories of calcium channel antagonists; and 3 ) differential calcium channel antagonists' effects on POC versus ROC.
MATERIALS AND METHODS
Adult Sprague-Dawley rats were sedated with an intramuscular injection of 25 mg/kg ketamine (Vetalar; Parke-Davis, Moms
Plains, NJ) and killed with an intraperitoneal injection of 250 mglkg thiopental sodium (Pentothal; Abbott Laboratories, Irving, TX). Newborns were killed with an intraperitoneal injection of 1 g/kg thiopental. Thoracic aortas were removed from 2-to 3-d-and 6-to 7-d (hereafter referred to as I -wk)-old rats of either sex and 12-wk-old male rats [respective animal weights: 7.8 k 0.01 g ( n =40); 13.3 f 0 . 3 g ( n = 53);and 391.1 f 5.3g(n = 57)]. Vessels were placed in cold Krebs' solution (containing in mM: NaCl 1 18, KC1 4.7, CaC12 2.2, MgS04 1.2, KH2P04 1.2, NaHCO, 25, di-sodium EDTA 0.025, and glucose 1 1), cleaned of connective tissue, and cut into rings of 4-mm width. Rings were mounted on two fine stainless steel wires that were passed through the lumen and connected to a Grass FT.03 force transducer (Grass Instrument Co., Quincy, MA) coupled to a Gould 2600s pen recorder (Gould Inc., Cleveland, OH) for continuous measurement of isometric force. Aortas were suspended in an organ bath with 25 mL of Krebs' solution (37°C; pH 7.4), gassed with 95% 0~5 % C02, and equilibrated for 60 min with a bath change every 15 min. Vessels were stretched to the optimal point on their length tension curve determined by equilibrium tension developed to a EDSo of NE (8, 9) . Optimal passive forces were: 2-3 d, 0.32 k 0.01 g; 1 wk, 0.38 f 0.01 g; and 12 wk, 3.2 f 0.03 g. Endothelial function was assessed by observing relaxation upon addition of 10 pM acetylcholine to rings preconstricted with a ED,, of NE. All experiments were performed with endothelium-intact vessels.
This study was approved by the Animal Care and Use Committee, Tripler Army Medical Center. Procedures on the rats were in accordance with National Institutes of Health policies and the Guide for the Care and Use of Laboratory Animals (NIH publication no. 85-23, revised 1985) .
Preliminary experiments. Before assessing the effects of calcium channel antagonists on single-dose KC1 or NE contractions, it was established that control contractions to both KC1 and NE were reproducible (time controls). Vessels at optimal passive force were exposed to a single ED50 of isotonic KC1 or NE and the equilibrium response allowed to develop. Vessels were then washed until optimal passive force was reattained and stabilized. After 30 min in control Krebs', the equilibrium response (R2) as a percentage of the initial equilibrium response (R,) was calculated (R2/R, x 100%): KCI: 2-3 d, 110 * 5 (n = 14); 1 wk, 99 f 3 ( n = 5); 12 wk, 111 ( n = 2); NE: 2-3 d, 1 0 9 k 3 (n = 9); 1 wk, 1 0 4 f 6 ( n = 6); 12 wk, 1 1 2 k 4 ( n =6).
Because KC1-induced contractions are dependent on extracellular calcium influx, virtually complete blockage of contraction can be obtained with calcium channel antagonists. Residual contraction is due to the hypertonicity induced by cumulative addition of KC1 to obtain the concentration response curve (10). A KC1 dose-response curve in the absence (control) and presence of 0.0 1 pM, 0.1 pM, and 1 pM verapamil is shown in Figure 1 . Very similar results using verapamil in aortas from adult male Wistar rats were reported by Koch et al.
(1 1). These authors also found that both 0.1 and 1 pM nifedipine equally inhibited KCIinduced contraction. For diltiazem, inhibition of intracellular calcium release during NE-induced contraction has been reported (12) for concentrations above 1 pM. Based on our results and such information in the literature (1 1, 12), doses of calcium channel antagonists selected for this study were 1 pM verapamil, 1 pM diltiazem, and 0.1 pM nifedipine. These doses blocked approximately 90% of a single isotonic EDSO of KC1 in aortas from 1 2-wk-old rats.
Experimental protocol. After a EDso of either isotonic KC1 (NaCl replaced with equimolar KCl) or NE, equilibrium control sustained contraction was allowed to develop. Preparations were washed until optimal passive force was reattained and stabilized. Preparations were then exposed for 30 min to the selected calcium channel antagonist, after which the EDs,, of isotonic KC1 or NE was repeated.
Drugs. The following drugs were used: NE, acetylcholine, verapamil, diltiazem (Sigma Chemical Co., St. Louis, MO), and nifedipine (Pfizer, New York, NY). NE, acetylcholine, verapamil, and diltiazem stock solutions (concentration not <0.5 mg/ mL) were made in distilled water and stored at -20°C. Nifedipine was dissolved in 100% ethanol and stored at -80°C. Aliquots were freshly diluted daily in distilled water. Each dose was administered in 100-pL aliquots, and drug concentrations are expressed as final molar concentration in the bath. Experiments with nifedipine were performed in a darkened room.
Statistical analysis. Two-way analysis of variance with Duncan's multiple range post hoc tests (13) were performed to determine differences among ages and calcium channel antagonists, with p < 0.05 considered significant. Data are expressed as means f SEM.
RESULTS
Because the amount of induced tone may affect relaxation (14) , within each age group we attempted to maintain a relatively constant single-dose control contraction to KC1 and NE. Shown in Table 1 are the control equilibrium contractions with the doses of KC1 and NE used. For all ages, both isotonic KC1 concentrations (2-3 d, 50 mM; 1 wk, 40 mM; 12 wk, 20-25 mM) and NE concentration (0.03 pM) approximated the ED50 values obtained in our previous study (8) .
At 2-3 d and 1 wk, we used male and female rats. No significant differences were noted between males and females in percent reduction with any of the three calcium channel antagonists for either KCI-or NE-induced contraction at either age. For example, percent reduction with verapamil for KC1 was: 2-3 d, female, 66 (n = 2); male, 68 f 13 (n = 5); 1 wk, female, 7 1 +-6 (n = 4); male 74 f 4 (n = 4). Percent reduction with verapamil for NE was: 2-3 d, female, 6 k 10 (n = 3); male, 6 -+ 1 1 (n = 3); 1 wk, female, 28 k 18 (n = 8); male, 29 f 13 (n = 5); p > 0.05.
Effect ~Jverapamil, diltiazem, and ngedipine on KCI-induced contraction (Fig. 2) . Both verapamil and diltiazem demonstrated significant age-related increases in effectiveness in blocking KCIinduced contractions. With verapamil, percent reduction of con- antagonists; **, significantly less than both 1 wk and 12 wk, same calcium channel antagonists; +, significantly greater than verapamil and diltiazem, same age; ++, significantly greater than diltiazem, same age (all p < 0.05).
trol contraction at 2-3 d was 67.7 f 4.2%, at 1 wk 72.5 + 1.8%, and at 12 wk 89.5 k 1.0%. Similarly, with diltiazem the percent reduction at 2-3 d was 64.6 + 2.9%, at 1 wk 73.5 + 3.0%, and at 12 wk 83.1 k 1.8%. There was a significant increase in percent reduction between 2 and 3 d and 1 wk for diltiazem but not for verapamil and between 1 and 12 wk for both antagonists ( p < 0.05). On the other hand, nifedipine was equally effective at all ages (2-3 d, 85.6 +-1.3%; 1 wk, 90.0 + 1.6%; 12 wk, 91.3 + 1.4% reduction, p > 0.05). In addition, nifedipine was significantly more effective than both verapamil and diltiazem in reducing contraction at 2-3 d and 1 wk ( p < 0.05).
Effect of verapamil, diltiazem, and ngedipine on NE-induced contraction (Fig. 3) . Similar to their effect on KC1-induced contraction, both verapamil and diltiazem demonstrated significant age-related increases in effectiveness in blocking NE-induced contractions. For verapamil, the percent reduction at 2-3 d was 6.2 f 3.9%, at 1 wk 28.0 k 4.8%, and at 12 wk 44.1 + 6.0%.
With diltiazem, the percent reduction at 2-3 d was 8.0 2 3.1 %, at 1 wk 20.5 + 3.9%, and at 12 wk 46.5 + 4.8%. There was a significant increase in percent reduction between 2 and 3 d and 1 wk for verapamil but not diltiazem, and between 1 and 12 w for both antagonists ( p < 0.05). In contrast, nifedipine was again equally effective at all ages (2-3 d, 42.0 k 6.8%; 1 wk, 35.8 +-3.9%; 12 wk, 37.5 f 3.2% reduction). Nifedipine was significantly more effective than both verapamil and diltiazem in reducing contraction at 2-3 d, and significantly more effective than diltiazem at 1 wk in reducing contraction ( p < 0.05).
DISCUSSION
Results herein contribute new and important information regarding the ontogeny of functional responses to calcium channel antagonists. Much of previous work on the influence of age on calcium channel antagonist effects in rat aorta has been on aging (I 5, 16), not ontogeny. Moreover, previous work on ontogeny of calcium channel antagonists has employed radioligand binding studies to examine changes in calcium I(d and B,. ,. Studies on perinatal development of 'H-nitrendipine (dihydropyridine) binding in several rat tissues indicate that increases in B,,, occur without changes in I(d (4) . Increases in B, , , during embryonic development in chick heart (5) and skeletal muscle (6) , with an immediate rise in K,, at hatching, have been reported. Although these studies give an indication that changes in binding site characteristics occur during ontogeny, they have not provided insight into the functional physiologic relevance of such changes, particularly in light of studies indicating that receptor binding and calcium channel function may be temporally unrelated (5). However, Hyman et al. (17) examined both dihydropyridine binding site changes and function in the neonatal period and found age-related increases in B,,, in isolated cells from rabbit stomach antrum, which is highly dependent on extracellular calcium to support contraction, and an age-related increase in contraction in isolated strips from antrum. These authors found no age-related increase in B,,, in the fundus, which utilizes intracellular calcium stores.
Present results demonstrate an increase in sensitivity to two categories of calcium channel antagonists during the same time period in rats when contractile responses to KC1 and NE are rapidly developing (8) . In contrast, results employing a third category of calcium channel antagonists, represented by nifedipine, indicate a different ontogeny than simply a generalized increase in calcium channel antagonists function, inasmuch as nifedipine was equally effective at 2-3 d through 12 wk.
Multiple mechanisms may be invoked to explain these observations. For example, these developmental changes may result from alterations in binding site characteristics. Most ontogenic studies of calcium channel antagonists binding sites have been performed using calcium channel antagonists that bind to the dihydropyridine binding site. Binding sites for verapamil and diltiazem are in close proximity, more so than either of them are to the nifedipine (dihydropyridine) binding site, although all three are allosterically linked (18) . In fact, Murphy et al. have proposed (19) that all nondihydropyridine calcium channel antagonists act at a single site that is allosterically linked to the dihydropyridine binding site. Later studies, however, have emphasized differences between verapamil and diltiazem binding sites (1, 2). No information is available as to the ontogeny of the verapamil and diltiazem binding sites and it is possible that they may differentiate and/or become distinct during ontogeny.
Ontogenic changes in calcium channel antagonists' function may also be due to other factors, such as differential access of calcium channel antagonists to their binding sites. It is of interest to note that both verapamil and diltiazem are classified as "use-" or "state-dependent", i.e. lipid penetration of these ionized drugs through the bilipid membrane is so low that entry to the calcium channel is dependent upon the state of the channel (i.e. open, resting, inactivated), which in turn depends on the membrane potential (20) . Although access of neutral dihydropyridines such as nifedipine is also voltage-dependent, such compounds, being lipophilic, may reach the calcium channel antagonist binding sites by penetration of the lipid bilayer as well. If access of verapamil and diltiazem to calcium channel antagonist binding sites is state-dependent, age-related alterations in this parameter would presumably affect verapamil and diltiazem similarly and to a greater extent than nifedipine. Thus, functional changes in calcium channel antagonists' effectiveness could occur without concomitant alterations in binding site characteristics.
There remains an ongoing debate as to whether POC and ROC are indeed distinct entities (l0,2 1). Chiu er al. (2 1) demonstrated in adult rat aorta that both POC and ROC exhibited the same sensitivity to inhibition by calcium channel antagonists (nifedipine and verapamil) of 45Ca influxes and suggested that POC and ROC in rat aorta share similar structural characteristics, but are gated separately and distinctly by their respective activators. Results herein demonstrate a qualitatively similar pattern of calcium channel antagonist effects between contractions mediated through POC and ROC, supporting the concept that these channels share similar functional and possibly structural characteristics. In addition, our previous work (8), which examined summation effects of POC-and ROC-mediated contractile antagonists, supports the concept of separate and distinct gating mechanisms.
Finally, in addition to agonist effect at the cell membrane, contractile agonist sensitivity to calcium channel antagonists depends also on the extent to which that agonist mobilizes intracellular calcium (22) . An expected finding was the reduced overall effectiveness of calcium channel antagonists during NEinduced contraction, which depends in part on intracellular Ca2+, compared to KC1-induced tone at all ages. However, although an age-related change in the ratio of extra/intracellular calcium utilization could explain our results with verapamil and diltiazem, it does not explain the results with nifedipine.
In summary, our results demonstrate that in rat aorta between 2 d and 12 wks: 1) there is a marked ontogeny of increasing responsiveness to the two categories of calcium channel antagonists, represented by verapamil and diltiazem, that are generally classified as use-dependent; 2) the third category of calcium channel antagonists (i.e. nifedipine), however, demonstrates no age-related change in effectiveness; and 3 ) this pattern is qualitatively similar for both KCl-and NE-induced contractions.
The clinical use of currently available calcium channel antagonists (1 8,23) and development of new selective calcium channel antagonists with perhaps new therapeutic indications requires an awareness of basic developmental aspects of calcium channel function. Results herein strongly suggest that the ontogeny of calcium channel antagonist function may vary depending on the site of binding within the calcium channel.
